Vectura Group has a total of 4079 patents globally, out of which 2246 have been granted. Of these 4079 patents, more than 32% patents are active. The United States of America is where Vectura Group has filed the maximum number of patents, followed by Europe and Japan. Parallelly, the United Kingdom seems to be the main focused R&D centre and also is the origin country of Vectura Group.
Vectura Group was founded in the year 1997. Vectura Group offers pharmaceutical development services. Research, development, and marketing of new therapeutic medicines are among its activities.
Do read about some of the most popular patents of Vectura Group which have been covered by us in this article and also you can find Vectura Group patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vectura Group patent portfolio.
How many patents does the CEO of Vectura Group have?
The CEO Michael Austwick have 0 patents.
How many patents does Vectura Group have?
Vectura Group has a total of 4079 patents globally. These patents belong to 849 unique patent families. Out of 4079 patents, 1308 patents are active.
How Many Patents did Vectura Group File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vectura Group Applications Filed | Vectura Group Patents Granted |
| 2023 | 1 | 7 |
| 2022 | 14 | 55 |
| 2021 | 20 | 80 |
| 2020 | 88 | 88 |
| 2019 | 40 | 84 |
| 2018 | 59 | 117 |
| 2017 | 80 | 140 |
| 2016 | 83 | 106 |
| 2015 | 130 | 152 |
| 2014 | 115 | 143 |
| 2013 | 154 | 87 |
| 2012 | 121 | 98 |
| 2011 | 135 | 103 |
How many Vectura Group patents are Alive/Dead?
How Many Patents did Vectura Group File in Different Countries?
Countries in which Vectura Group Filed Patents
| Country | Patent |
| United States Of America | 443 |
| Europe | 400 |
| Japan | 274 |
| United Kingdom | 243 |
| Germany | 218 |
| Australia | 206 |
| China | 171 |
| Canada | 152 |
| Spain | 151 |
| Hong Kong (S.A.R.) | 113 |
| Austria | 110 |
| India | 106 |
| Mexico | 100 |
| Denmark | 97 |
| Norway | 83 |
| Korea (South) | 82 |
| New Zealand | 76 |
| Singapore | 74 |
| Brazil | 74 |
| Israel | 72 |
| Portugal | 70 |
| South Africa | 69 |
| Poland | 61 |
| Taiwan | 48 |
| Hungary | 41 |
| Russia | 38 |
| Slovenia | 31 |
| Argentina | 28 |
| Italy | 21 |
| Cyprus | 20 |
| Czech Republic | 18 |
| Indonesia | 16 |
| Slovakia | 10 |
| Ukraine | 9 |
| Eurasia | 8 |
| Philippines | 7 |
| Malaysia | 7 |
| Turkey | 6 |
| Viet Nam | 6 |
| Finland | 6 |
| Sweden | 5 |
| Chile | 5 |
| Albania | 4 |
| Croatia | 4 |
| Romania | 4 |
| Brunei | 4 |
| Lithuania | 4 |
| Malta | 3 |
| Serbia | 3 |
| Colombia | 3 |
| Ecuador | 3 |
| San Marino | 3 |
| Iceland | 3 |
| Africa | 3 |
| Estonia | 2 |
| Switzerland | 2 |
| Cambodia | 2 |
| Georgia | 2 |
| Luxembourg | 2 |
| Bulgaria | 1 |
| El Salvador | 1 |
| Saudi Arabia | 1 |
| Gulf Cooperation Council | 1 |
| Tunisia | 1 |
| Uruguay | 1 |
| Dominican Republic | 1 |
| Yugoslavia/Serbia and Montenegro | 1 |
| Morocco | 1 |
| United Arab Emirates | 1 |
| Macao | 1 |
| Pakistan | 1 |
| Egypt | 1 |
| Belgium | 1 |
Where are Research Centres of Vectura Group Patents Located?
10 Best Vectura Group Patents
WO2005037353A1 is the most popular patent in the Vectura Group portfolio. It has received 382 citations so far from companies like Glaxo Group, Novartis and Oriel Therapeutics.
Below is the list of 10 most cited patents of Vectura Group:
| Publication Number | Citation Count |
| WO2005037353A1 | 382 |
| US6645466B1 | 287 |
| US6475467B1 | 277 |
| US6634576B2 | 258 |
| US6811792B2 | 212 |
| US6347629B1 | 199 |
| US6586006B2 | 177 |
| US6461591B1 | 150 |
| US7056495B2 | 140 |
| US6585958B1 | 133 |
How many inventions of other companies were rejected due to Vectura Group patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Vectura Group invention. They couldn’t because Vectura Group had protected those before them.
Examiners at the USPTO referred 176 Vectura Group patents in 115 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Vectura Group patent portfolio are Boehringer Ingelheim, Chiesi Farmaceutici and Jagotec.
List of the Companies whose Patents were rejected citing Vectura Group –
| Company | Number of Patent Applications that faced Rejection Citing Vectura Group Patents | Number of Rejections (102 & 103) |
| Boehringer Ingelheim | 21 | 63 |
| Chiesi Farmaceutici | 16 | 31 |
| Jagotec | 15 | 43 |
| Philip Morris | 10 | 22 |
| Mexichem Fluor | 10 | 22 |
| Otitopic | 9 | 17 |
| Glaxo Group | 7 | 13 |
| Aptar France | 6 | 12 |
| Iceutica | 6 | 13 |
| Pacira Pharmaceuticals | 6 | 9 |
Count of 102 and 103 Type Rejections based on Vectura Group Patents
Top Vectura Group Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6634576B2 | 15 |
| US7950389B2 | 14 |
| US6645466B1 | 13 |
| US6585958B1 | 12 |
| US8910625B2 | 11 |
| US6586006B2 | 10 |
| US8168218B2 | 10 |
| US20020039596A1 | 9 |
| US6604698B2 | 9 |
| US20080127972A1 | 9 |
| US20100258118A1 | 9 |
| US6337092B1 | 8 |
| US20070256685A1 | 8 |
| US6475467B1 | 8 |
| US20060147389A1 | 8 |